A published author, inventor and entrepreneurial Chief Executive Officer with extensive experience optimising R&D operations, teams, $MM investments and global strategic alliances to deliver product innovation, market leadership and $MM results for start-ups and SME’s in the Pharmaceutical sector. An ambitious, results focused and trusted advisor who demonstrates the unique scientific knowledge backed by the financial and commercial expertise to forge lucrative partnerships with leading companies and deliver biological drug development and production as well as preclinical and clinical drug approvals. With proven expertise building and leading highly technical and multidisciplinary teams whilst balancing corporate social responsibility, regulatory compliance and business objectives, this highly innovative and all round team player will consistently create value and growth with exceptional persistence and integrity.